OTCMKTS:HSDT
Helius Medical Technologies, Inc. Stock News
$2.42
-0.450 (-15.68%)
At Close: May 06, 2024
Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript
08:45pm, Thursday, 28'th Mar 2024
Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
07:05am, Friday, 15'th Mar 2024
NEWTOWN, Pa., March 15, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neu
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
07:00am, Thursday, 07'th Mar 2024
NEWTOWN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neur
Helius Medical Technologies to Present at NobleCon19 Annual Conference
07:47am, Thursday, 30'th Nov 2023
NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuro
Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript
08:11am, Sunday, 12'th Nov 2023
Helius Medical Technologies, Inc (NASDAQ:HSDT ) Q3 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Michelle Gable Bilski - In-Site Communications, IR Dane Andreeff - Pre
-- Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023 -- -
3 Metaverse Stocks to Invest in for the Internet's Next Evolution
02:34pm, Friday, 20'th Oct 2023
In September, sales at U.S. retailers defied expectations by increasing 0.7%, demonstrating that households possess substantial purchasing power, a crucial factor in sustaining economic growth. A surg
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
07:05am, Wednesday, 13'th Sep 2023
-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation technologies, and the science behind its effectiveness,
Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?
08:32am, Tuesday, 05'th Sep 2023
Helius Medical Technologies (NASDAQ: HSDT ) stock is rising higher on Tuesday as investors react to the neurotechnology company regaining listing compliance. Helius Medical Technologies says that it
Helius Medical Technologies, Inc. (HSDT) Q2 2023 Earnings Call Transcript
08:44pm, Thursday, 10'th Aug 2023
Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Michelle Bilski - In-Site Communications, IR Dane Andreeff - President
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates
07:46pm, Thursday, 10'th Aug 2023
Helius Medical Technologies, Inc. (HSDT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.97 per share a year ago.
Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023
04:05pm, Wednesday, 02'nd Aug 2023
NEWTOWN, Pa., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neur
Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest
04:05pm, Wednesday, 14'th Jun 2023
NEWTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuro
Helius Medical Technologies to Present at LD Micro Invitational XIII 2023
07:05am, Thursday, 25'th May 2023
Newtown, Pennsylvania--(Newsfile Corp. - May 25, 2023) - Helius Medical Technologies, Inc. (NASDAQ: HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neu
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
04:05pm, Thursday, 04'th May 2023
NEWTOWN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuro
